Dysphagia Management Market

Dysphagia is characterized by difficulty  swallowing food or liquids. The causes of the disease are large bites of food, insufficient chewing, dry mouth, pills or eating very hot food. Dysphagia treatment involves the use of products that change the texture of food  and other products, such as tubes, to facilitate the swallowing process. Although, there are some medications to treat dysphagia, not all conditions can be treated with medication. Dysphagia is the medical name for difficulty swallowing. Swallowing difficulty is the inability to swallow foods or liquids with ease. People who have a hard time swallowing may choke on their food or liquid when trying to swallow. Dysphagia can be caused by functional or structural abnormalities of the oral cavity, pharynx, esophagus, or gastric cardia, and can be acute or chronic depending on the cause. New-onset dysphagia warrants evaluation for esophageal cancer and possibly head and neck cancer, but is also associated with a variety of benign conditions.

Market Dynamics                                               

Major players in the market are also focused for the advanced monitoring for patients thus it is expected to drive the market growth in near future. For instance, on October 17, 2022 an article published by the British Medical Journal (the bmj), U.K on investigating dysphagia explains dysphagia describes difficulties with eating, drinking, and swallowing practices. Malnutrition and aspiration pneumonia can result from benign or malignant dysphagia. These patients usually require interdisciplinary team care. Speech-language pathologists play an important role in the evaluation and management of dysphagia and should be involved early with the nutrition team if there are concerns about food intake.

Key features of the study:

• This report provides an in-depth analysis of the Global Dysphagia Management Market, and provides market size (US$ 4.4 billion) and compound annual growth rate (6.2%) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global dysphagia management market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Eisai Co. Ltd, C.R. Bard Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd, Nestle Health Science, Kent Precision Food Group Inc., Bracco Diagnostics Inc., Phagenesis Ltd, Nutricia Advanced Medical Nutrition, Cook medical Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Global Dysphagia Management Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dysphagia management market.

Detailed Segmentation:

• Global Dysphagia Management Market, By Product Type:
  • Drug
    • Proton pump inhibitors
  • Feeding Tubes
    • Naso-Gastric
    • Tubes PEG tubes
  • Nutritional solutions
    • Thickener
    • Beverages
    • Purees
• Global Dysphagia Management Market, By Indications :
  • Oropharangeal Dysphagia
  • Esophageal Dypshagia
• Global Dysphagia Management Market, By Distribution channel:
  • Hospital pharmacies
  • Retail pharmacies
  • Drug store
  • Specialty clinics
• Global Dysphagia Management Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Eisai Co. Ltd
  • C.R. Bard Inc. (Becton, Dickinson and Company)
  • Hormel Health Labs
  • AstraZeneca
  • Cipla Ltd
  • Nestle Health Science
  • Kent Precision Food Group Inc.
  • Bracco Diagnostics Inc.
  • Phagenesis Ltd
  • Nutricia Advanced Medical Nutrition
  • Cook medical Inc.